·Confidence 90%
Dow Futures Decline Due to Swiss Drug Company's Setback
Key takeaways
- Dow futures are underperforming the S&P 500 following a late-stage setback for a cardiovascular drug from a Swiss company, impacting market sentiment.
Analysis
Dow futures are underperforming the S&P 500 following a late-stage setback for a cardiovascular drug from a Swiss company, impacting market sentiment.
0 likes · 0 dislikes